Literature DB >> 11320456

Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple risk factor intervention trial.

R J Prineas1, P M Rautaharju, G Grandits, R Crow.   

Abstract

Risk prediction for electrocardiographic (ECG) left ventricular hypertrophy related criteria, used in clinical trials, and epidemiologic studies of clinically healthy people, has depended in the past on dichotomous classification of ECG LVH criteria. Recent analyses have shown that more sensitive methods of LVH ECG classification without loss of specificity are needed to improve on dichotomous classification. This was done by relating six year incident significant change in continuous score criteria of ECG LVH to the 16 year (10 year post trial) coronary heart disease (CHD) and cardiovascular disease (CVD) mortality among 12,866 men, free of clinical disease, aged 35 to 57 years at baseline in the Multiple Risk Factor Intervention Trial. It was found that significant change in continuous ECG LVH criteria was a stronger independent predictor of future CHD and CVD mortality than was use of dichotomous classification of the same criteria. It was also demonstrated that increase in continuous ECG LVH indexes, below previous dichotomous thresholds independently (of standard CVD risk factors, including increase in obesity-indicated by an increase in adult BMI) predicted excess CHD and CVD mortality and that combinations of continuous indices increases the specificity and relative risk in clinically disease-free middle-aged men.

Entities:  

Mesh:

Year:  2001        PMID: 11320456     DOI: 10.1054/jelc.2001.23360

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  16 in total

1.  Long-Term Effects of an Intensive Lifestyle Intervention on Electrocardiographic Criteria for Left Ventricular Hypertrophy: The Look AHEAD Trial.

Authors:  Tina E Brinkley; Andrea Anderson; Elsayed Z Soliman; Alain G Bertoni; Frank Greenway; William C Knowler; Stephen P Glasser; Edward S Horton; Mark A Espeland
Journal:  Am J Hypertens       Date:  2018-04-13       Impact factor: 2.689

2.  Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Michael E Ernst; Barry R Davis; Elsayed Z Soliman; Ronald J Prineas; Peter M Okin; Alokananda Ghosh; William C Cushman; Paula T Einhorn; Suzanne Oparil; Richard H Grimm
Journal:  J Am Soc Hypertens       Date:  2016-11-09

3.  Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial.

Authors:  Michael E Ernst; James D Neaton; Richard H Grimm; Gary Collins; William Thomas; Elsayed Z Soliman; Ronald J Prineas
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

Review 4.  Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.

Authors:  Jonathan P Law; Luke Pickup; Davor Pavlovic; Jonathan N Townend; Charles J Ferro
Journal:  J Hum Hypertens       Date:  2022-09-22       Impact factor: 2.877

5.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Elsayed Z Soliman; Walter T Ambrosius; William C Cushman; Zhu-Ming Zhang; Jeffrey T Bates; Javier A Neyra; Thaddeus Y Carson; Leonardo Tamariz; Lama Ghazi; Monique E Cho; Brian P Shapiro; Jiang He; Lawrence J Fine; Cora E Lewis
Journal:  Circulation       Date:  2017-05-16       Impact factor: 29.690

6.  Association of left ventricular hypertrophy with cognitive decline and dementia risk over 20 years: The Atherosclerosis Risk In Communities-Neurocognitive Study (ARIC-NCS).

Authors:  Faye L Norby; Lin Y Chen; Elsayed Z Soliman; Rebecca F Gottesman; Thomas H Mosley; Alvaro Alonso
Journal:  Am Heart J       Date:  2018-08-02       Impact factor: 4.749

7.  Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography.

Authors:  Edward P Havranek; Caroline D B Emsermann; Desiree N Froshaug; Frederick A Masoudi; Mori J Krantz; Rebecca Hanratty; Raymond O Estacio; L Miriam Dickinson; John F Steiner
Journal:  J Electrocardiol       Date:  2008-03-14       Impact factor: 1.438

8.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.

Authors:  Elsayed Z Soliman; Robert P Byington; J Thomas Bigger; Gregory Evans; Peter M Okin; David C Goff; Haiying Chen
Journal:  Hypertension       Date:  2015-10-12       Impact factor: 10.190

9.  Electrocardiogram Performance in the Diagnosis of Left Ventricular Hypertrophy in Hypertensive Patients With Left Bundle Branch Block.

Authors:  Paula Freitas Martins Burgos; Bráulio Luna Filho; Francisco de Assis Costa; Maria Teresa Nogueira Bombig; Dilma de Souza; Henrique Tria Bianco; Japy Angelini Oliveira Filho; Maria Cristina de Oliveira Izar; Francisco Antonio Helfenstein Fonseca; Rui Póvoa
Journal:  Arq Bras Cardiol       Date:  2016-12-19       Impact factor: 2.000

10.  Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.

Authors:  Peter M Okin; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Journal:  J Am Heart Assoc       Date:  2017-11-18       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.